Terms: = Small Cell Lung Cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Diagnosis
1039 results:
1. Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients.
Gristina V; Russo TDB; Barraco N; Gottardo A; Pepe F; Russo G; Fulfaro F; Incorvaia L; Badalamenti G; Troncone G; Malapelle U; Russo A; Bazan V; Galvano A
Sci Rep; 2024 Sep; 14(1):22141. PubMed ID: 39333636
[TBL] [Abstract] [Full Text] [Related]
2. [Advances in diagnosis and Targeted Therapy of G719X/L861Q/S768I Mutant
Non-small cell lung cancer].
Wang Y; Zheng J; Zhu Y; Zhou J
Zhongguo Fei Ai Za Zhi; 2024 Aug; 27(8):593-604. PubMed ID: 39318252
[TBL] [Abstract] [Full Text] [Related]
3. diagnosis, Treatment Patterns, and Outcomes in Real-World Patients with RET Fusion-Positive Non-small cell lung cancer in China.
Lu S; Shen L; Wang Q; Chen H; Zhao Y; Li Y; Segall G; Khanal M; Zhang X; Ding D; Shao J; Pang L
Adv Ther; 2024 Nov; 41(11):4248-4265. PubMed ID: 39316291
[TBL] [Abstract] [Full Text] [Related]
4. Management of Pulmonary Toxicities Associated with Systemic Therapy in Non small cell lung cancer.
Velimirovic M; Brignola M; Chheng E; Smith M; Hassan KA
Curr Treat Options Oncol; 2024 Oct; 25(10):1297-1311. PubMed ID: 39302574
[TBL] [Abstract] [Full Text] [Related]
5. Real-World Biomarker Test Ordering Practices in Non-small cell lung cancer: Interphysician Variation and Association With Clinical Outcomes.
Baron JM; Widatalla S; Gubens MA; Khalil F
JCO Precis Oncol; 2024 Aug; 8():e2400039. PubMed ID: 39208373
[TBL] [Abstract] [Full Text] [Related]
6. Real-World Treatment Patterns, Health Outcomes, and Healthcare Resource Use in Advanced Common egfr-Positive Non-small cell lung cancer Patients Treated with Osimertinib in Alberta.
Cheung WY; Carbonell C; Navani V; Sangha RS; Ewara EM; Elia-Pacitti J; Iczkovitz S; Jarada TN; Warkentin MT
Curr Oncol; 2024 Jul; 31(8):4382-4396. PubMed ID: 39195310
[TBL] [Abstract] [Full Text] [Related]
7. [Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2024 edition)].
Oncology Society of Chinese Medical Association
Zhonghua Yi Xue Za Zhi; 2024 Sep; 104(34):3175-3213. PubMed ID: 39193605
[TBL] [Abstract] [Full Text] [Related]
8. Machine learning enabled classification of lung cancer cell lines co-cultured with fibroblasts with lightweight convolutional neural network for initial diagnosis.
Germain A; Sabol A; Chavali A; Fitzwilliams G; Cooper A; Khuon S; Green B; Kong C; Minna J; Kim YT
J Biomed Sci; 2024 Aug; 31(1):84. PubMed ID: 39180048
[TBL] [Abstract] [Full Text] [Related]
9. Current clinical practice and physicians' insights on Chinese patients with advanced non-small cell lung cancer habouring epidermal growth factor receptor 20 insertion mutation.
Shi Y; Xu Y; Wang M
BMC Cancer; 2024 Aug; 24(1):1043. PubMed ID: 39179992
[TBL] [Abstract] [Full Text] [Related]
10. Efficacy and Safety of Anlotinib in egfr-Positive Patients with Advanced lung Adenocarcinoma Compared with Chemotherapy: A Retrospective Study.
Cai C; Shen Q; Shao J; Qu J; Zhou S; Zhou J
Technol Cancer Res Treat; 2024; 23():15330338241279111. PubMed ID: 39175430
[TBL] [Abstract] [Full Text] [Related]
11. [Non-small cell lung cancer with Metachronous Mutations of egfr and ALK Genes:
A Case Report and Literature Review].
Kong X; Wang M; Tang Q; Sun M; Hu J
Zhongguo Fei Ai Za Zhi; 2024 Jul; 27(7):559-564. PubMed ID: 39147711
[TBL] [Abstract] [Full Text] [Related]
12. [Chinese Expert Consensus on the Standardized diagnosis and Treatment of
Non‑small cell lung cancer with egfr Exon 20 Insertion Mutations (2024 Edition)].
Chinese Society of Clinical Oncology Non-small Cell Lung Cancer Committee
Zhongguo Fei Ai Za Zhi; 2024 Jul; 27(7):485-494. PubMed ID: 39147702
[TBL] [Abstract] [Full Text] [Related]
13. Utilizing Plasma-Based Next-Generation Sequencing to Expedite the Diagnostic Process in Suspected lung cancer: A Case Report.
Hung CM; Wu CT; Jain S; Wu CE
Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125693
[TBL] [Abstract] [Full Text] [Related]
14. 'Plasma first' approach for detecting epidermal growth factor receptor mutation in advanced non-small cell lung carcinoma.
Rathor A; Malik PS; Tanwar P; Khurana S; Baskarane H; Pushpam D; Nambirajan A; Jain D
J Cancer Res Clin Oncol; 2024 Jul; 150(7):371. PubMed ID: 39066920
[TBL] [Abstract] [Full Text] [Related]
15. Interstitial lung Diseases and Non-small cell lung cancer: Particularities in Pathogenesis and Expression of Driver Mutations.
Sampsonas F; Bosgana P; Bravou V; Tzouvelekis A; Dimitrakopoulos FI; Kokkotou E
Genes (Basel); 2024 Jul; 15(7):. PubMed ID: 39062713
[TBL] [Abstract] [Full Text] [Related]
16. Overview of the Role of Liquid Biopsy in Non-small cell lung cancer (NSCLC).
Ospina AV
Clin Oncol (R Coll Radiol); 2024 Oct; 36(10):e371-e380. PubMed ID: 39048406
[TBL] [Abstract] [Full Text] [Related]
17. [Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2024 edition)].
Oncology Society of Chinese Medical Association
Zhonghua Zhong Liu Za Zhi; 2024 Sep; 46(9):805-843. PubMed ID: 39045625
[TBL] [Abstract] [Full Text] [Related]
18. Nephrotoxicity of targeted therapy used to treat lung cancer.
Li Q; Lin J; Hao G; Xie A; Liu S; Tang B
Front Immunol; 2024; 15():1369118. PubMed ID: 39026680
[TBL] [Abstract] [Full Text] [Related]
19. A non-enhancing, T2 fluid-attenuated inversion recovery hyperintense, diffusion-restricting brainstem lesion in an egfr tyrosine kinase inhibitor-treated non-small-cell lung cancer patient.
Yuen CA; Bao S; Kong XT
Biomark Med; 2024; 18(9):431-439. PubMed ID: 39007837
[TBL] [Abstract] [Full Text] [Related]
20. Detecting small cell Transformation in Patients with Advanced egfr Mutant lung Adenocarcinoma through Epigenomic cfDNA Profiling.
El Zarif T; Meador CB; Qiu X; Seo JH; Davidsohn MP; Savignano H; Lakshminarayanan G; McClure HM; Canniff J; Fortunato B; Li R; Banwait MK; Semaan K; Eid M; Long H; Hung YP; Mahadevan NR; Barbie DA; Oser MG; Piotrowska Z; Choueiri TK; Baca SC; Hata AN; Freedman ML; Berchuck JE
Clin Cancer Res; 2024 Sep; 30(17):3798-3811. PubMed ID: 38912901
[TBL] [Abstract] [Full Text] [Related]
[Next]
